Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Meridian Bioscience Company Profile (NASDAQ:VIVO)

Consensus Ratings for Meridian Bioscience (NASDAQ:VIVO) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s)
Consensus Rating:Hold (Score: 1.67)
Consensus Price Target: $19.60 (15.57% upside)

Analysts' Ratings History for Meridian Bioscience (NASDAQ:VIVO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/5/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
12/3/2014ZacksDowngradeNeutral -> Underperform$15.80ViewTweet This Rating  Share This Rating on StockTwits
11/6/2014Robert W. BairdDowngradeOutperform -> Neutral$22.00ViewTweet This Rating  Share This Rating on StockTwits
11/4/2014ZacksUpgradeUnderperform -> Neutral$18.90ViewTweet This Rating  Share This Rating on StockTwits
9/3/2014ZacksDowngradeNeutral -> Underperform$18.40ViewTweet This Rating  Share This Rating on StockTwits
4/25/2014Cowen and CompanyLower Price Target$24.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Canaccord GenuityBoost Price TargetHold$20.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013WedbushUpgradeUnderperform -> Neutral$17.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
7/16/2013Cowen and CompanyDowngradeOutperform -> Market Perform$23.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
4/26/2013Craig HallumDowngradeBuy -> Hold$24.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
4/12/2013SidotiInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/22/2012 forward)